Sun.Jan 12, 2025

article thumbnail

Tune raises $175M for hepatitis B medicine, epigenetic research

BioPharma Drive: Drug Pricing

The biotech plans to use the funding to advance clinical testing of an epigenetic silencing therapy it hopes could treat chronic hepatitis B infections.

article thumbnail

FDA’s Issues Draft Guidance on Accelerated Approval: A Substantial Evidentiary and Procedural Overhaul to this High-Profile Pathway

FDA Law Blog: Drug Discovery

By Charles G. Raver & James E. Valentine & Ellis Unger & Frank J. Sasinowski On December 5, 2024, FDA published a new draft guidance on accelerated approval providing a much needed and substantial update to its guidance on the pathway. FDAs application and use of accelerated approval has evolved dramatically since it was first developed by the Agency to help address the HIV/AIDS epidemic in the late 1980s.

FDA 64
article thumbnail

Gregor Mendel's Vanishing Act

Codon

On a winter’s day in 1884, a group of Augustinian friars gathered around a fire and tossed papers into its hungry flames. Thousands of pages withered and burned, each containing hand-written text, charts, and data from a lifetime of work. By the time the smoke dissipated into an azure sky, it had all vanished. The papers eaten by those flames belonged to Gregor Mendel, a quiet scientist and religious man today revered as the “father” of genetics.

DNA 55